Hexagon Nutrition

Hexagon Nutrition

UPCOMING

IPO Date: 5 Jun - 9 Jun 2026

Listing Date: 12 Jun 2026

Price Range

Rs.42 - Rs.45

Issue Size

139 Cr

Min Investment

13,986

Lot Size

333 Shares

Schedule of Hexagon Nutrition

Issue open date

5 Jun 2026

Issue close date

9 Jun 2026

UPI mandate deadline

9 Jun 2026 (5 PM)

Allotment finalization

10 Jun 2026

Share credit

11 Jun 2026

Listing date

12 Jun 2026

Mandate end date

24 Jun 2026

Issue size

Funds Raised in the IPOAmount
Overall139 Cr
Fresh Issue0 Cr
Offer for Sale138.87 Cr

Allotment DetailsNew

Allotment TimelineDetails
Allotment Date10 Jun 2026
Allotment Link{Link}

Grey Market PremiumNew

Grey Market Premium (GMP) is the premium at which the shares are traded in the grey market. It gives a fair idea about the listing price of the IPO shares. The GMP can be positive or negative based on the demand and supply of the shares in the grey market.

DateIpo PriceGMPEstimated Listing Price
4 Jun 2026451257 (26.67%)
3 Jun 202645045 (0%)
2 Jun 202645045 (0%)
1 Jun 202645045 (0%)
31 May 202645045 (0%)
30 May 202645045 (0%)
29 May 202645045 (0%)
28 May 202645045 (0%)
27 May 202645045 (0%)
26 May 202645045 (0%)

Performance Hexagon Nutrition

Issue PriceListing GainCurrent Market PriceP/L
Rs.42 - Rs.45............

About Hexagon Nutrition

Hexagon Nutrition is a research-oriented nutrition company engaged in the development, manufacturing, and marketing of a diversified portfolio of nutrition and wellness products. The company operates across multiple segments, including branded wellness and clinical nutrition products, premix formulations, and therapeutic nutrition solutions such as ready-to-use foods (RUFs) and micronutrient powders (MNPs). Established in 1993, the company initially operated as a micronutrient formulations player and subsequently expanded into branded health and clinical nutrition products. Hexagon Nutrition operates manufacturing facilities in Maharashtra, Tamil Nadu, and Uzbekistan, with two Indian facilities located in Special Economic Zones (SEZs). The company exports its products to more than 75 countries and serves domestic and international FMCG companies, healthcare organisations, and public health programmes. Its operations are supported by integrated manufacturing processes and certifications, including FSSC 22000, GMP, and ISO 9001:2015.

Founded in1993
Managing directorMr Vikram Arun Kelkar
Parent organization

Financial Overview

Strengths

  • Integrated nutrition company with capabilities from R&D to manufacturing and marketing.
  • Diverse product portfolio covering premixes, clinical, and therapeutic nutrition.
  • Strong presence in micronutrient premixes for FMCG companies.
  • Supplier to global public health programmes for micronutrient powders.
  • Focus on research-driven and quality-oriented product development.

Risks

  • Heavy dependence on the premix formulation segment for revenue.
  • High revenue concentration from a limited number of customers.
  • Exposure to raw material price volatility due to a lack of long-term contracts.
  • Risk of product quality issues leading to liability and reputational damage.
  • Dependence on successful R&D and new product commercialisation.

Subscription Figures

CategorySubscription (No. of times)
Qualified Institutional Buyers (QIBs)N/A
Non-Institutional Investors (NIIs)N/A
Retail Individual Investors (RIIs)N/A
EmployeeN/A
TotalN/A